CardioSignal by Precordior

We’re Hiring: Quality Manager! CardioSignal is revolutionizing heart disease detection with groundbreaking technology. We're seeking an experienced Quality Manager to lead our compliance efforts and drive innovation in digital health: ▪️ Ensure compliance and maintain regulatory standards ▪️ Work as part of a dedicated quality team—you’re never on your own ▪️ Play a vital role in delivering cutting-edge products in digital health Location: Flexible, with some presence in Turku, Finland. Ready to make a difference? Apply now! Applications are reviewed on a rolling basis. https://lnkd.in/gzMHzfHK #NowHiring #HealthcareJobs #QualityManager #DigitalHealth #MedicalDevices #ISO13485

What a week for CardioSignal at HLTH USA 2024 in Las Vegas! A big shoutout to our team members, Juuso Blomster, Lasse Leppäkorpi, and Ilkka Korhonen, who represented us. Thank you for showcasing our work with such dedication. The #HLTHUSA conference is fantastic. We had the privilege to engage with a remarkable crowd – pioneers, changemakers, and top-tier decision-makers pushing the boundaries of digital health. Special thanks to Nhu Nguyen and Sasha Spellman and the whole team from AgeTech Collaborative™ from AARP for hosting us. See you all soon again!

We are thrilled to announce that Blaz Mrevlje, MD, PhD is joining CardioSignal as our new Medical Director! With over 15 years of experience in cardiology, interventional cardiology, and clinical research, Dr. Mrevlje will lead our medical development and help us advance our mission to make heart disease detection more accessible through our innovative smartphone-based technology. "Dr. Mrevlje's depth of experience across various facets of cardiology, combined with his impressive track record in clinical research and medical leadership, makes him the ideal choice to take on the role of Medical Director at CardioSignal," says CEO Juuso Blomster. Dr. Mrevlje is passionate about leveraging accessible technology to transform patient care and democratize heart disease detection. We're excited to welcome him to the team and continue innovating in cardiac health together! Read more here: https://lnkd.in/dPdJB6-t #healthtech #cardiology #innovation #CardioSignal

Exciting times at the MedTech Innovator Conference in Toronto! Our CEO, Juuso Blomster, had the honor of taking part in an engaging panel discussion titled "Showcase: Cardiology Diagnostics" this week. The session gathered passionate innovators in cardiac health to explore advancements, share insights, and discuss the future of diagnostics in cardiology. It was an inspiring conversation, and we were thrilled to see the enthusiasm and collaboration among so many MedTech professionals. A huge thank you to the organizers for putting together such a well-structured and insightful event. #Cardiology #Diagnostics #Medtech #HealthcareInnovation #CardioSignal

A new position is now open in our team. Apply yourself or ping a friend!

Patient care doesn’t stop at the hospital doors. We’re excited to announce a collaboration with Mølholm Heart Center, renowned for excellence in cardiac ablation, to bring cutting-edge heart monitoring directly to patients' homes. After being discharged, patients can now continue monitoring their heart health in case of atrial fibrillation episodes using CardioSignal’s easy-to-use app. This partnership redefines post-procedure care, enhancing both patient safety and comfort through innovative digital health solutions. 👉 Curious about how we’re shaping the future of post-ablation care? Read more: https://lnkd.in/dCuN4brJ #CardioSignal #DigitalHealth #HeartCare #AtrialFibrillation #HealthcareInnovation #PatientSafety #CardiacAblation

CardioSignal is incredibly honored to announce that we've been accepted into the prestigious MedTech Innovator accelerator program! With over 1,400 applicants and approximately 65 companies selected, this is a significant milestone for us, and we're thrilled to be part of this leading global program driving healthcare innovation. 🚀 Our team is committed to making a difference in cardiac care, and this opportunity brings us one step closer to transforming how heart health is monitored and managed. We couldn't have achieved this without the support of our amazing team and partners. 🙌 To celebrate this moment, and as a part of the program, we've put together a special promotional video showcasing our journey and mission. We'd love for you to check it out, give it a thumbs up, and share it with your network! Your support means the world to us. 👉 Watch and like our video here: https://lnkd.in/dHAYJbDN Let's continue to innovate and bring better heart health solutions to people everywhere! 💓 #MedTechInnovator #CardioSignal #HealthcareInnovation #HeartHealth #DigitalHealth #MedTech #Cardiology #HealthTech #Innovation #Startups

CardioSignal’s CEO, co-founder, and cardiologist Juuso Blomster just presented data at the European Society of Cardiology annual meeting 2024 in London on atrial fibrillation detection reliability among people suspected of various heart conditions. High detection accuracy for atrial fibrillation detection was established among a diverse group of patients suspected of arrhythmias, heart failure and coronary artery disease. Detection reliability is key when designing remote care initiatives in larger populations. “We need to prepare ourselves for the future where high-risk individuals are regularly screened in high volume for heart diseases such as atrial fibrillation or heart failure. This is a necessity if we are to address the growing burden of heart disease with the available healthcare resources”, Dr. Blomster says. Read the full story: https://lnkd.in/daBNiD-e

Attending #ESCCongress? Our team is excited to present new data at the session “Transforming #populationhealth through mobile technology” at 14:30 on Saturday, August 31. Our CEO Juuso Blomster will present how smartphone performs as a measuring device in the detection of #atrialfibrillation in populations referred to #cardiology. 💡 Smartphones as methods for care delivery solve many challenges in reaching various patient populations. 💡 People already spend considerable amounts of time on their phones daily (approx. 5h / per day). 💡 The adoption of smartphones is around 80–86% in countries such as Germany, France and the UK. 💡 According to a #ORCHA study made in the UK, more than half of those aged 65+ support the move to digital health 💡 Population health initiatives are needed to reduce the burden of #heartdisease among those in highest risk European Society of Cardiology annual meeting is being held in London on August 30 – September 2. Tune in live or attend virtual sessions: ➡ https://lnkd.in/dMyY_dmQ #mhealth #healthtech #digitalhealth #remotepatientmonitoring #heartdisease #hearthealth #remotecare #mobilehealth #cardiovascular #healthcare #atrialfibrillation #earlydetection #gyrocardiography

In our latest blog, we explain why atrial fibrillation and diabetes are particularly challenging together. Both are becoming increasingly common, and with diabetes, atrial fibrillation can even be more asymptomatic. Dive deeper: https://lnkd.in/d8YzAW_i #diabetes #atrialfibrillation #digitalhealth #earlydetection #prevention #healthcare #cardiovascular #hearthealth #hearthealthy #heartdisease #mhealth #diabetesmanagement